Stay updated with breaking news from Nti Ige. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a letter, the FDA stated that additional efficacy data are required to support an approval for chronic spontaneous urticaria (CSU), according to the manufacturers of dupilumab.
The AGA issued a Clinical Practice Update on alpha-gal syndrome.
Rhinovirus infection is associated with stimulating histamine-releasing factor (HRF) and HRF-reactive immunoglobulin E for increasing severity of asthma and exacerbations.
The application for FDA approval for CSU is based on data from a pair of phase 3 trials in two different populations.
Misinformation and disinformation about urticaria abound online, and doctors need to combat the false claims with facts, researchers in Ireland report.